Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Long non-coding RNAs (lncRNAs) play crucial roles in tumorigenesis.
• The specific involvement of lncRNAs in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL) remains underexplored.
• ETV6/RUNX1-positive BCP-ALL is a frequent and significant subtype of pediatric leukemia.

Purpose of the Study:

• To comprehensively analyze the lncRNA transcriptome in ETV6/RUNX1-positive BCP-ALL.
• To identify a specific lncRNA expression signature associated with this leukemia subtype.
• To determine which lncRNAs are regulated by the ETV6/RUNX1 oncogenic fusion protein.

Main Methods:

• Analysis of primary leukemia patient samples to establish an ETV6/RUNX1 specific lncRNA expression signature.
• Integration of lncRNA signature with RNA sequencing data from BCP-ALL cell lines.
• In vitro studies using an ETV6/RUNX1 knockdown model to identify regulated lncRNAs.

Main Results:

• A unique lncRNA expression signature comprising 596 transcripts was identified for ETV6/RUNX1-positive BCP-ALL.
• Four lncRNAs (lnc-NKX2-3-1, lnc-TIMM21-5, lnc-ASTN1-1, and lnc-RTN4R-1) were found to be directly regulated by the ETV6/RUNX1 fusion protein.
• Inactivation of lnc-RTN4R-1 and lnc-NKX2-3-1 led to significant alterations in gene expression in ETV6/RUNX1-positive cells.

Conclusions:

• A distinct lncRNA expression signature is associated with ETV6/RUNX1-positive BCP-ALL.
• lnc-RTN4R-1 and lnc-NKX2-3-1 are identified as potentially functionally important lncRNAs in the pathogenesis of this leukemia subtype.
• These findings provide novel insights into the molecular mechanisms underlying ETV6/RUNX1-positive BCP-ALL.